Literature DB >> 22325255

Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?

Nicola J Robertson1, Sidhartha Tan, Floris Groenendaal, Frank van Bel, Sandra E Juul, Laura Bennet, Matthew Derrick, Stephen A Back, Raul Chavez Valdez, Frances Northington, Alistair Jan Gunn, Carina Mallard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22325255      PMCID: PMC4048707          DOI: 10.1016/j.jpeds.2011.12.052

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  155 in total

1.  Maternal allopurinol during fetal hypoxia lowers cord blood levels of the brain injury marker S-100B.

Authors:  Helen L Torrance; Manon J Benders; Jan B Derks; Carin M A Rademaker; Arie F Bos; Paul Van Den Berg; Mariangela Longini; Giuseppe Buonocore; MariaElena Venegas; Hernando Baquero; Gerard H A Visser; Frank Van Bel
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

2.  Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation.

Authors:  Daqing Ma; Ta Lim; Jing Xu; Haidy Tang; Yanjie Wan; Hailin Zhao; Mahmuda Hossain; Patrick H Maxwell; Mervyn Maze
Journal:  J Am Soc Nephrol       Date:  2009-01-14       Impact factor: 10.121

3.  Cooling combined with immediate or delayed xenon inhalation provides equivalent long-term neuroprotection after neonatal hypoxia-ischemia.

Authors:  Marianne Thoresen; Catherine E Hobbs; Tommy Wood; Ela Chakkarapani; John Dingley
Journal:  J Cereb Blood Flow Metab       Date:  2009-01-14       Impact factor: 6.200

4.  Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy.

Authors:  Changlian Zhu; Wenqing Kang; Falin Xu; Xiuyong Cheng; Zhan Zhang; Liting Jia; Ling Ji; Xiaoyan Guo; Hong Xiong; George Simbruner; Klas Blomgren; Xiaoyang Wang
Journal:  Pediatrics       Date:  2009-07-27       Impact factor: 7.124

Review 5.  General anesthetics and the developing brain.

Authors:  George K Istaphanous; Andreas W Loepke
Journal:  Curr Opin Anaesthesiol       Date:  2009-06       Impact factor: 2.706

6.  The common inhalational anesthetic sevoflurane induces apoptosis and increases beta-amyloid protein levels.

Authors:  Yuanlin Dong; Guohua Zhang; Bin Zhang; Robert D Moir; Weiming Xia; Edward R Marcantonio; Deborah J Culley; Gregory Crosby; Rudolph E Tanzi; Zhongcong Xie
Journal:  Arch Neurol       Date:  2009-05

7.  Erythropoietin sustains cognitive function and brain volume after neonatal stroke.

Authors:  Fernando F Gonzalez; Regina Abel; C Robert Almli; Dezhi Mu; Michael Wendland; Donna M Ferriero
Journal:  Dev Neurosci       Date:  2009-08-11       Impact factor: 2.984

Review 8.  Update of the stroke therapy academic industry roundtable preclinical recommendations.

Authors:  Marc Fisher; Giora Feuerstein; David W Howells; Patricia D Hurn; Thomas A Kent; Sean I Savitz; Eng H Lo
Journal:  Stroke       Date:  2009-02-26       Impact factor: 7.914

9.  Ascorbic acid combined with ibuprofen in hypoxic ischemic encephalopathy: a randomized controlled trial.

Authors:  H Aly; L Abd-Rabboh; M El-Dib; F Nawwar; H Hassan; M Aaref; S Abdelrahman; A Elsayed
Journal:  J Perinatol       Date:  2009-02-26       Impact factor: 2.521

Review 10.  Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review.

Authors:  Lex W Doyle; Caroline A Crowther; Philippa Middleton; Stéphane Marret
Journal:  Obstet Gynecol       Date:  2009-06       Impact factor: 7.661

View more
  57 in total

Review 1.  Pathophysiology of glia in perinatal white matter injury.

Authors:  Stephen A Back; Paul A Rosenberg
Journal:  Glia       Date:  2014-03-31       Impact factor: 7.452

2.  Additive Neuroprotection of a 20-HETE Inhibitor with Delayed Therapeutic Hypothermia after Hypoxia-Ischemia in Neonatal Piglets.

Authors:  Junchao Zhu; Bing Wang; Jeong-Hoo Lee; Jillian S Armstrong; Ewa Kulikowicz; Utpal S Bhalala; Lee J Martin; Raymond C Koehler; Zeng-Jin Yang
Journal:  Dev Neurosci       Date:  2015-02-25       Impact factor: 2.984

Review 3.  Preclinical Models of Encephalopathy of Prematurity.

Authors:  Lauren L Jantzie; Shenandoah Robinson
Journal:  Dev Neurosci       Date:  2015-02-18       Impact factor: 2.984

4.  Antenatal pharmacokinetics and placental transfer of N-acetylcysteine in chorioamnionitis for fetal neuroprotection.

Authors:  Donald B Wiest; Eugene Chang; Deanna Fanning; Sandra Garner; Toby Cox; Dorothea D Jenkins
Journal:  J Pediatr       Date:  2014-07-23       Impact factor: 4.406

5.  Partial neuroprotection by nNOS inhibition during profound asphyxia in preterm fetal sheep.

Authors:  Paul P Drury; Joanne O Davidson; Lotte G van den Heuij; Sidhartha Tan; Richard B Silverman; Haitao Ji; Arlin B Blood; Mhoyra Fraser; Laura Bennet; Alistair Jan Gunn
Journal:  Exp Neurol       Date:  2013-10-09       Impact factor: 5.330

6.  A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy.

Authors:  Kasper J Kyng; Torjus Skajaa; Sigrid Kerrn-Jespersen; Christer S Andreassen; Kristine Bennedsgaard; Tine B Henriksen
Journal:  J Vis Exp       Date:  2015-05-16       Impact factor: 1.355

Review 7.  White matter injury in the preterm infant: pathology and mechanisms.

Authors:  Stephen A Back
Journal:  Acta Neuropathol       Date:  2017-05-22       Impact factor: 17.088

Review 8.  Bench to cribside: the path for developing a neuroprotectant.

Authors:  Nelina Ramanantsoa; Bobbi Fleiss; Myriam Bouslama; Boris Matrot; Leslie Schwendimann; Charles Cohen-Salmon; Pierre Gressens; Jorge Gallego
Journal:  Transl Stroke Res       Date:  2012-12-21       Impact factor: 6.829

Review 9.  Cerebral white and gray matter injury in newborns: new insights into pathophysiology and management.

Authors:  Stephen A Back
Journal:  Clin Perinatol       Date:  2014-03       Impact factor: 3.430

Review 10.  Erythropoietin and Neonatal Neuroprotection.

Authors:  Sandra E Juul; Gillian C Pet
Journal:  Clin Perinatol       Date:  2015-05-14       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.